Changes in the Histology of Lung Cancer in Northern Italy: Impact on Incidence and Mortality

Author:

Mangone Lucia1ORCID,Marinelli Francesco1ORCID,Bisceglia Isabella1ORCID,Zambelli Alessandro1,Zanelli Francesca2,Pagano Maria2,Alberti Giulia2,Morabito Fortunato3ORCID,Pinto Carmine2ORCID

Affiliation:

1. Epidemiology Unit, Azienda Unità Sanitaria Locale, IRCCS di Reggio Emilia, 42122 Reggio Emilia, RE, Italy

2. Medical Oncology Unit, Azienda Unità Sanitaria Locale, IRCCS di Reggio Emilia, 42122 Reggio Emilia, RE, Italy

3. Biotechnology Research Unit, Azienda Sanitaria Provinciale di Cosenza, 87051 Aprigliano, CS, Italy

Abstract

This study assessed the incidence, mortality, and survival of lung cancer subtypes of NSCSLC (non-small-cell lung cancer), SCLC (small-cell lung cancer), and other morphologies. It is an observational epidemiological study using 7197 cases from the Reggio Emilia Cancer Registry recorded between 2001 and 2020 in males and females. The incidence of NSCLC in 5104 males indicates a significant 3% annual increase until 2013 and then a decline of −3.2% that is not statistically significant; until 2014, mortality increased significantly (3.2%), but it then decreased non-significantly (−12.1%), especially squamous cell cancer. In 2093 females, the incidence and mortality trends continued to rise significantly through 2012, and then they began to slightly decline (not statistically significant). The two-year relative survival of NSCLC increased from 32% to 38% in males and from 42% to 56% in females. SCLC in males decreased significantly both in incidence and mortality, while in women, it showed a slight increase (significantly for incidence but not for mortality). This study is important because it analyzes the decrease in lung cancer in males and the increase in females in relation to the different histotypes. Our study’s findings confirmed a decline in male incidence and death beginning in 2013. We were unable to determine if the drop in cigarette smoking and the introduction of new drugs such as EGFR in first-line therapy were responsible for the lower incidence.

Funder

Italian Ministry of Health–Ricerca Corrente Annual Program 2024

Publisher

MDPI AG

Subject

Cancer Research,Oncology

Reference50 articles.

1. Introduction to the 2015 World Health Organi-zation classification of tumors of the lung, pleura, thymus, and heart;Travis;J. Thorac. Oncol.,2015

2. The Effect of Advances in Lung-Cancer Treatment on Population Mortality;Howlader;N. Engl. J. Med.,2020

3. Pathology of non-small cell lung cancer. New diagnostic approaches;Linnoila;Hematol. Oncol. Clin. N. Am.,1990

4. Historical Changes in Histological Diagnosis of Lung Cancer;Utada;J. Epidemiol.,2019

5. Precision Medicine in Lung Cancer Theranostics: Paving the Way from Traditional Technology to Advance Era;Guan;Cancer Control.,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3